Joseph L. Maniaci

University of North Carolina at Chapel Hill

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Successful Treatment with Tezepelumab for an Adult with Refractory and Severe Fibrostenotic Eosinophilia Esophagitis: A Case Report”.

Successful Treatment with Tezepelumab for an Adult with Refractory and Severe Fibrostenotic Eosinophilia Esophagitis: A Case Report

Case Reports in Gastroenterology(2025)10.1159/000549673

N/A

0DataRank · unranked

1 citations

Allison J. Burbank, Evan S. Dellon, Joseph L. Maniaci

Research Communication: Mepolizumab Improves Histologic Severity as Measured by the EoEHSS in Adolescents and Adults With Eosinophilic Oesophagitis in a Multicenter, Randomised, Double‐Blind, Placebo‐Controlled Clinical Trial

Alimentary Pharmacology & Therapeutics(2025)10.1111/apt.70216

N/A

0DataRank · unranked

0 citations

Alina C. Iuga, Christine Bookhout, Lindsay Cortright, Kacie B. Walker, Susan E. Moist +4 more